Source link : https://health365.info/foxj1-gene-might-force-resistance-to-taxane-chemotherapy-in-complicated-prostate-most-cancers/
A gene known as FOXJ1 might force resistance to taxane chemotherapy right through remedy for complicated prostate most cancers, in step with a brand new learn about led by way of investigators at Weill Cornell Medication and Beth Israel Deaconess Clinical Middle. The findings supply vital new insights into why sufferers with metastatic illness incessantly forestall responding to a key elegance of life-prolonging chemotherapy medication after to start with reaping rewards. For the reason that taxanes stay the one chemotherapy brokers with demonstrated survival get advantages in complicated prostate most cancers, figuring out how and why resistance develops is an pressing want for sufferers.
The learn about, revealed Feb. 14 in Nature Communications, means that docs could possibly measure FOXJ1 gene job in tumors to expect which sufferers may just expand drug resistance and transfer immediately to choice treatments, fending off useless toxicity.
“This is a previously unrecognized role for the FOXJ1 transcription factor, and it could serve as a potential biomarker to help us identify patients who are more likely to benefit from these types of treatments,” mentioned Dr. Paraskevi Giannakakou, professor of pharmacology in drugs and director of laboratory analysis within the Department of Hematology and Clinical Oncology, who co-led this analysis. “In addition, the research opens the door to developing future therapies that could block this resistance pathway and…
—-
Author : admin
Publish date : 2026-03-10 18:09:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8